Article
EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Gene - 25 Apr 2013
Piao Ying, Liu Zhaozhe, Ding Zhenyu, Xu Long, Guo Fang, Sun Qingqing, Xie Xiaodong
Abstract excerpt
Emerging evidences from preclinical and clinical studies have shown that epidermal growth factor (EGF) has some effectiveness against endogenously arising carcinogenesis. Functional +61A>G polymorphism (rs4444903 A>G) in the promoter region of the EGF gene was observed to modulate EGF levels, thus affecting the susceptibility to gastrointestinal cancer; but individually published studies showed inconclusive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
